# OnCo record grid (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/grid/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "grid", "NCT01271712" ;
  schema:name "GRID"@en ;
  schema:description "GRID showed that regorafenib held back GIST that had already escaped both imatinib and sunitinib, and gave patients a third line of targeted treatment."@en ;
  schema:url <https://onco.cc/trials/grid/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01271712> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/gist-imatinib-resistant/>, <https://onco.cc/cancers/gist/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:drugs <https://onco.cc/drugs/regorafenib/> ;
  onco:companies <https://onco.cc/companies/bayer/> ;
  onco:people <https://onco.cc/people/george-demetri/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-grid-regorafenib-gist-lancet-2013/> .